Cronos Australia has launched new functionality within its upgraded CanView platform, enabling pharmacies to receive both prescriptions and TGA approvals directly from doctors prescribing through the system.
All 3,000 pharmacy accounts have moved to the new version without disruption, the company said, describing the transition as "seamless" with "no interruption to regular operations".
The updated platform also gives patients the ability to order repeat prescriptions, and provides pharmacies with auto-matching functionality for products and dosage forms based on TGA approvals.
Cronos announced it has completed stage three of CanView 2.0, which targets doctors and patients, with those features due to go live in early October.
Doctors will gain the ability to generate electronic prescriptions from within the CanView platform. They will also be able to store TGA approval documents in a single location and send those approvals to pharmacies alongside electronic prescriptions.
Patients will be able to receive prescriptions from CanView prescribers and place repeat orders with pharmacies through the mobile app.
Cronos Australia chief executive Rodney Cocks said: "We are very pleased to be delivering such a wide range of important new features to our large and growing number of CanView users. The network effect on the platform is clear which will drive further patient, prescriber and pharmacist onboarding.
"We are confident that the improved functionality of the CanView 2.0 platform will not only provide a superior user experience but help Cronos Australia to maintain its current market-leading position."
Cocks attributed the progress to an "aligned focused board and executive with proven execution capabilities".
The announcement came one day after CDA co-founder and major Cronos shareholder Dr Matua Jansen called for a "complete separation of the board and executive management" and indicated his intention to pursue the removal of Cocks and director Guy Headley from the board.
Cronos shares rose 7% to $0.60 in trading today.
